These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5122994)

  • 1. [Specific therapeutic effect of ribonucleotides in tapetoretinal dystrophies].
    Fuks BB; Shershevskaia SF; Levina FG; Shabanova ME
    Vestn Akad Med Nauk SSSR; 1971; 26(7):63-8. PubMed ID: 5122994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment results using the preparation ENKAD in patients with peripheral tapetoretinal abiotrophy].
    Katsnel'son LA; Maslova-Khoroshilova IP; Eliseeva RF; Dnestrova GI
    Vestn Oftalmol; 1988; 104(6):54-61. PubMed ID: 3242209
    [No Abstract]   [Full Text] [Related]  

  • 3. [RNA and ribonucleotide preparations in the treatment of tapeto-retinal dystrophy].
    Trutneva KV; Katsnel'son LA; Bogoslovskii AI; Fuks BB; Milevskaia TI
    Vestn Oftalmol; 1972; 2():68-70. PubMed ID: 4664148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in the use of RNA in the complex treatment of tapetoretinal dystrophy].
    Shershevskaia SF; Fuks BB; Potapova LN; Levina FG; Denisova TP
    Vestn Oftalmol; 1971; 3():59-63. PubMed ID: 5160956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial using RNA preparations for treatment of tapeto-retinal dystrophies].
    Shershevskaia SF; Levina FG
    Vestn Akad Med Nauk SSSR; 1978; (10):40-4. PubMed ID: 706719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenesis of hereditary retinal dystrophies].
    Fuks BB
    Vestn Akad Med Nauk SSSR; 1978; (10):29-35. PubMed ID: 706717
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of adenosine triphosphoric acid for the treatment of dystrophic retinal diseases].
    Dobromyslov AN; Fursova IP
    Vestn Oftalmol; 1970; 1():64-7. PubMed ID: 5474449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relationship between the results of pathogenetic therapy and hereditary retinal dystrophy in man and animals].
    Avtsyn AP; Fuks BB; Shabanova ME; Tereshchenko OD
    Vestn Akad Med Nauk SSSR; 1977; (1):71-9. PubMed ID: 842141
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of enkad on the development of experimental chloroquine retinopathy].
    Ivanina TA; Zueva MV; Tsapenko IV
    Patol Fiziol Eksp Ter; 1991; (5):39-42. PubMed ID: 1806892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of tapetoretinal dystrophy with an adenosine triphosphoric acid preparation].
    Mikhaĭlovskaia IE; Salganik RI
    Oftalmol Zh; 1982; 37(3):157-9. PubMed ID: 7133586
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cosaldon in the treatment of senile macular degeneration].
    Gerkowicz K
    Klin Oczna; 1973 Aug; 43(8):893-7. PubMed ID: 4742598
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical-biochemical evaluation of the therapeutic effects of vitohepatit in acute viral hepatitis].
    Levina LD; Ambalov IuM; Ostrovskaia AA
    Ter Arkh; 1975; 47(8):62-6. PubMed ID: 1188652
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of ribonucleotide replacement therapy in certain diseases].
    Fuks BB; Shershevskaia SF; Popova LM; Shnaper AL
    Biull Eksp Biol Med; 1969 Sep; 68(9):23-6. PubMed ID: 5399821
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of superphonoelectrophoresis on chorioretinal dystrophy].
    Gvarishvili EP; Dushin NV
    Vestn Oftalmol; 1999; 115(4):19-21. PubMed ID: 10523961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optic nerve drusen and decreasing of visual acuity].
    Oftalmologia; 2007; 51(1):95-8. PubMed ID: 17605280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic significance of color and quantitative perimetry in tapetoretinal degeneration of the retina and chorioretinitis].
    Zakharchenko VM
    Oftalmol Zh; 1971; 26(7):532-6. PubMed ID: 5149654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of the use of vasoactive preparation pikamilon in pigmented retinal abiotrophy].
    Davydova GA; Mukha AI
    Vestn Oftalmol; 1995; 111(3):20-2. PubMed ID: 7483195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal disease expression in Bardet-Biedl syndrome-1 (BBS1) is a spectrum from maculopathy to retina-wide degeneration.
    Azari AA; Aleman TS; Cideciyan AV; Schwartz SB; Windsor EA; Sumaroka A; Cheung AY; Steinberg JD; Roman AJ; Stone EM; Sheffield VC; Jacobson SG
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5004-10. PubMed ID: 17065520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet.
    Dagnelie G; Zorge IS; McDonald TM
    Optometry; 2000 Mar; 71(3):147-64. PubMed ID: 10970259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Time course of visual functions in patients with pigmentary retinal degeneration after surgical treatment with biomaterial "Alloplant"].
    Galimova VU
    Vestn Oftalmol; 2001; 117(3):20-3. PubMed ID: 11521429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.